Form4insider filings, from the source

SEC Form 4 · accession 0000905718-16-001804

Kindred Biosciences, Inc. · KIN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 12, 2016
Accepted (ET)
Dec 14, 2016 · 7:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.0001 par value per shareF1,F2,F3Dec 12, 2016P3,112$4.74A2,001,862ISee Footnotes
Common Stock, $0.0001 par value per shareF2,F3Dec 13, 2016P1,148$4.75A2,003,010ISee Footnotes
Common Stock, $0.0001 par value per shareF2,F3Dec 14, 2016P4,074$4.75A2,007,084ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses